Mylan was founded in 1961 in White Sulphur Springs. In 1965, the company
relocated to Morgantown, where its operations in the state remain based. The
company’s impact on West Virginia today is significant and wide-ranging, as
measured by its effect on the state’s total gross domestic product; the number of jobs
supported; and influence on local healthcare, education and charitable institutions.

Access to Medicine

In 2017, Mylan generics saved West Virginia

~$212 million

We believe everyone deserves the opportunity to live a healthy life, including you. That’s why our business is focused on providing a sustainable supply of high quality medicine that is accessible, around the world.

Innovation & Science

1,400+
Science & Technology roles in Morgantown

Home to one of Mylan’s two Global R&D Centers of Excellence

BILLIONS OF DOSES manufactured in WV for patients in America.*

*Manufactured from domestic and imported components.

Public & Health Policy

One of the most powerful ways to serve patients in need is by speaking out on their behalf.

We work closely with government, trade associations, healthcare providers, patient advocacy groups and others to shape policy to help people in the U.S. enjoy better health.

Community Impact

Mylan is one of WV’s largest employers.

Mylan has a workforce of ~3,000 people in West Virginia.
and is one of WV’s largest employers
Meet Jeff, a Mylan scientist in WV.
Morgantown is home to Mylan’s largest manufacturing plant and the company’s largest workforce in any one city in the world. See how Mylan is delivering Better Health for a Better West Virginia

Mylan's School
Access Program - WV

Over the past five years, Mylan has provided 5,866 free epinephrine auto-injectors to 495 schools in West Virginia, ~54% of the state’s schools.

Several years ago, we recognized that epinephrine auto-injectors needed to be as accessible as defibrillators are in public spaces. So Mylan advocated for legislation to permit “undesignated” epinephrine auto-injectors in schools – meaning a prescription could be in a school’s name rather than in a child’s name and any individual experiencing an anaphylactic emergency would have access to the epinephrine auto-injectors. Today, 48 states have adopted such laws, and Mylan has donated nearly 1 million epinephrine auto-injectors to more than 73,000 schools around the country through the school access program.

Since the program began, epinephrine auto-injectors provided through the program have been used at least 4 times in West Virginia in the school setting.